AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 26-50/101
CURRENT CLINICAL PATHOPHYSIOLOGIC CONSIDERATIONS IN ESSENTIAL-HYPERTENSION
Authors: FROHLICH ED
Citation: Ed. Frohlich, CURRENT CLINICAL PATHOPHYSIOLOGIC CONSIDERATIONS IN ESSENTIAL-HYPERTENSION, The Medical clinics of North America, 81(5), 1997, pp. 1113
THE 6TH REPORT OF THE ,-EVALUATION,-AND-TREATMENT-OF-HIGH-BLOOD-PRESSURE
Authors: BLACK HR COHEN JD KAPLAN NM FERDINAND KC CHOBANIAN AV DUSTAN HP GIFFORD RW MOSER M SHEPS SG AGODOA L AUGUST PA BAKRIS GL BURT V BUSSE W CARTER BL CHESLEY FD CLEEMAN J COHN JN CREGLER LL CRESPO C CUSHMAN WC CUTLER J DARROW MD DEQUATTRO VL DEVEREUX RB DWORKIN LD ELLIOTT WJ EPSTEIN M FALKNER B FERRARIO CM FLACK JM FRISHMAN W FROHLICH ED GREEN LA GRIMM RH HAGBERG JM HALL WD HANDLER J HAVAS S HILL MN HORAN MJ HSUEH WA HYMAN BN IZZO JL JAMERSON K KILEY JP KOCHAR MS KOLASA KM KRAKOFF LR LEVY D LINDHEIMER MD LUEPKER RV MALONE MEL MASSIE B MATERSON BJ MERCHANT J MESSERLI FH MILLER NH MOORE MA MUSTONEALEXANDER L OPARIL S PERRY HM PICKERING TG PRATT JH RAM CVS RANDALL OS REED JW ROBERTS RW ROCCELLA EJ ROGUS SD SAUNDERS E SCHRON E SCHWARTZ G SIBAI BM SNYDER D SOWERS JR STAMLER J TEMPLE R TEXTOR S THOM T VIDT DG WEBER M WEINBERGER MH WEINSHILBOUM R WHELTON PK WHISNANT JP WIEBERS DO WINSTON MC WRIGHT JT LENFANT C CASSER L COLMAN PJ EDWARDS T FEELEY DM GAJEWSKI J LEVINE D MANGER W MARSHALL EC NICKEY WA ROBERT RW SECREST BG SINGER EH WHISNANT JP WILSON GJ YOUNG JM BACHMAN JW CAMPESE VM CARR AA HAND M HOLDEN DC JAMIESON MJ JULIUS S MENSAH GA PRISANT M SULLIVAN JM WILSON DJ MOROSCO G ANDERSON DE WAUGH D
Citation: Hr. Black et al., THE 6TH REPORT OF THE ,-EVALUATION,-AND-TREATMENT-OF-HIGH-BLOOD-PRESSURE, Archives of internal medicine, 157(21), 1997, pp. 2413-2446
ACE-INHIBITION REDUCES LEFT-VENTRICULAR MASS-INDEPENDENT OF PRESSURE WITHOUT AFFECTING CORONARY FLOW AND FLOW RESERVE IN SPONTANEOUSLY HYPERTENSIVE RATS
Authors: KANEKO K SUSIC D NUNEZ E FROHLICH ED
Citation: K. Kaneko et al., ACE-INHIBITION REDUCES LEFT-VENTRICULAR MASS-INDEPENDENT OF PRESSURE WITHOUT AFFECTING CORONARY FLOW AND FLOW RESERVE IN SPONTANEOUSLY HYPERTENSIVE RATS, The American journal of the medical sciences, 314(1), 1997, pp. 21-27
IMPACT AND INTERPRETATION OF MULTIPLE GUIDELINES AND CONSENSUS DOCUMENTS
Authors: FROHLICH ED
Citation: Ed. Frohlich, IMPACT AND INTERPRETATION OF MULTIPLE GUIDELINES AND CONSENSUS DOCUMENTS, Journal of human hypertension, 10, 1996, pp. 63-67
EFFECTS OF CALCIUM-ENTRY BLOCKERS ON DISTRIBUTION OF BLOOD-VOLUME
Authors: OREN S GOSSMAN E FROHLICH ED
Citation: S. Oren et al., EFFECTS OF CALCIUM-ENTRY BLOCKERS ON DISTRIBUTION OF BLOOD-VOLUME, American journal of hypertension, 9(7), 1996, pp. 628-632
HYPERTENSION OVERVIEW - 1996
Authors: FROHLICH ED
Citation: Ed. Frohlich, HYPERTENSION OVERVIEW - 1996, Current opinion in cardiology, 11(5), 1996, pp. 455-456
HYDROCHLOROTHIAZIDE EXACERBATES NITRIC OXIDE-BLOCKADE NEPHROSCLEROSISWITH GLOMERULAR HYPERTENSION IN SPONTANEOUSLY HYPERTENSIVE RATS
Authors: ONO Y ONO H FROHLICH ED
Citation: Y. Ono et al., HYDROCHLOROTHIAZIDE EXACERBATES NITRIC OXIDE-BLOCKADE NEPHROSCLEROSISWITH GLOMERULAR HYPERTENSION IN SPONTANEOUSLY HYPERTENSIVE RATS, Journal of hypertension, 14(7), 1996, pp. 823-828
LOSARTAN REDUCES CARDIAC MASS AND IMPROVES CORONARY FLOW RESERVE IN THE SPONTANEOUSLY HYPERTENSIVE RAT
Authors: KANEKO K SUSIC D NUNEZ E FROHLICH ED
Citation: K. Kaneko et al., LOSARTAN REDUCES CARDIAC MASS AND IMPROVES CORONARY FLOW RESERVE IN THE SPONTANEOUSLY HYPERTENSIVE RAT, Journal of hypertension, 14(5), 1996, pp. 645-653
ANTIHYPERTENSIVE THERAPY - SAFETY AND EFFICACY OF DRUGS AND PUBLICATIONS
Authors: FROHLICH ED ZANCHETTI A
Citation: Ed. Frohlich et A. Zanchetti, ANTIHYPERTENSIVE THERAPY - SAFETY AND EFFICACY OF DRUGS AND PUBLICATIONS, Journal of hypertension, 14(3), 1996, pp. 273-275
POST HOC ANALYSIS - USE AND DANGERS IN PERSPECTIVE - DISCUSSION
Authors: FROHLICH ED HANSSON L ELLIOTT HL MANCIA G MACMAHON S
Citation: Ed. Frohlich et al., POST HOC ANALYSIS - USE AND DANGERS IN PERSPECTIVE - DISCUSSION, Journal of hypertension, 14, 1996, pp. 24-25
THE HYPERTENSION TRIALS - DISCUSSION
Authors: FROHLICH ED SEVER PS HANSSON L MENARD J
Citation: Ed. Frohlich et al., THE HYPERTENSION TRIALS - DISCUSSION, Journal of hypertension, 14, 1996, pp. 33-34
COST-EFFECTIVENESS CALCULATIONS FROM TRIALS - DISCUSSION
Authors: VANZWIETEN PA AMBROSIONI E SEVER PS MACMAHON S FROHLICH ED KRAKOFF LR ZANCHETTI A SWALES JD HANSSON L MANCIA G MENARD J
Citation: Pa. Vanzwieten et al., COST-EFFECTIVENESS CALCULATIONS FROM TRIALS - DISCUSSION, Journal of hypertension, 14, 1996, pp. 52-54
THE OPTIMAL BLOOD-PRESSURE REDUCTION - DISCUSSION
Authors: FROHLICH ED RAHN KH HANSSON L SEVER PS AGABITIROSEI E ARAKAWA K LINDHOLM L
Citation: Ed. Frohlich et al., THE OPTIMAL BLOOD-PRESSURE REDUCTION - DISCUSSION, Journal of hypertension, 14, 1996, pp. 58-59
AMBULATORY BLOOD-PRESSURE MONITORING - DISCUSSION
Authors: MENARD J MANCIA G FROHLICH ED HAMET P AGABITIROSEI E ZANCHETTI A
Citation: J. Menard et al., AMBULATORY BLOOD-PRESSURE MONITORING - DISCUSSION, Journal of hypertension, 14, 1996, pp. 66-68
DOES ANTIHYPERTENSIVE THERAPY PROTECT THE KIDNEY IN ESSENTIAL-HYPERTENSION - DISCUSSION
Authors: FROHLICH ED RODICIO JL HANSSON L VANZWIETEN PA SALVETTI A
Citation: Ed. Frohlich et al., DOES ANTIHYPERTENSIVE THERAPY PROTECT THE KIDNEY IN ESSENTIAL-HYPERTENSION - DISCUSSION, Journal of hypertension, 14, 1996, pp. 75-76
TRIALS INVESTIGATING THE ANTIATHEROSCLEROTIC EFFECTS OF ANTIHYPERTENSIVE DRUGS - DISCUSSION
Authors: DEVEREUX R ZANCHETTI A VANZWIETEN PA SALVETTI A RAHN KH HANSSON L SAFAR M FROHLICH ED
Citation: R. Devereux et al., TRIALS INVESTIGATING THE ANTIATHEROSCLEROTIC EFFECTS OF ANTIHYPERTENSIVE DRUGS - DISCUSSION, Journal of hypertension, 14, 1996, pp. 80-81
CLINICAL-TRIALS - WHAT MORE IS NEEDED - A CRITICAL-VIEW - DISCUSSION
Authors: HANSSON L SWALES JD FROHLICH ED MENARD J ZANCHETTI A
Citation: L. Hansson et al., CLINICAL-TRIALS - WHAT MORE IS NEEDED - A CRITICAL-VIEW - DISCUSSION, Journal of hypertension, 14, 1996, pp. 86-87
ACKNOWLEDGMENT TO REVIEWERS
Authors: FROHLICH ED
Citation: Ed. Frohlich, ACKNOWLEDGMENT TO REVIEWERS, Hypertension, 28(6), 1996, pp. 921-926
CONTROVERSIES IN THE GENETIC-ANALYSIS OF HYPERTENSIVE DISEASES
Authors: RE RN FROHLICH ED
Citation: Rn. Re et Ed. Frohlich, CONTROVERSIES IN THE GENETIC-ANALYSIS OF HYPERTENSIVE DISEASES, Hypertension, 28(5), 1996, pp. 880-880
GENETICS-96 - SATELLITE SYMPOSIUM OF THE ISH - JUNE 21, 1996, GLASGOW, SCOTLAND - INTRODUCTION
Authors: DOMINICZAK AF FROHLICH ED
Citation: Af. Dominiczak et Ed. Frohlich, GENETICS-96 - SATELLITE SYMPOSIUM OF THE ISH - JUNE 21, 1996, GLASGOW, SCOTLAND - INTRODUCTION, Hypertension, 28(5), 1996, pp. 894-894
L-ARGININE REVERSES SEVERE NEPHROSCLEROSIS IN AGED SPONTANEOUSLY HYPERTENSIVE RATS (SHR)
Authors: ONO H ONO Y FROHLICH ED
Citation: H. Ono et al., L-ARGININE REVERSES SEVERE NEPHROSCLEROSIS IN AGED SPONTANEOUSLY HYPERTENSIVE RATS (SHR), Hypertension, 28(3), 1996, pp. 86-86
ALL INHIBITION WITH LOSARTAN AND OR ENALAPRIL IMPROVES CORONARY FLOW RESERVE WHILE REDUCING LEFT-VENTRICULAR MASS/
Authors: NUNEZ E FROHLICH ED
Citation: E. Nunez et Ed. Frohlich, ALL INHIBITION WITH LOSARTAN AND OR ENALAPRIL IMPROVES CORONARY FLOW RESERVE WHILE REDUCING LEFT-VENTRICULAR MASS/, Hypertension, 28(3), 1996, pp. 103-103
ANGIOTENSIN-II INCREASES LEFT-VENTRICULAR MASS WITHOUT AFFECTING MYOSIN ISOFORM MESSENGER-RNAS
Authors: SUSIC D NUNEZ E FROHLICH ED PRAKASH O
Citation: D. Susic et al., ANGIOTENSIN-II INCREASES LEFT-VENTRICULAR MASS WITHOUT AFFECTING MYOSIN ISOFORM MESSENGER-RNAS, Hypertension, 28(2), 1996, pp. 265-268
INTERVENTION TRIALS - CONCERNS AND PUBLISHING PITFALLS
Authors: FROHLICH ED
Citation: Ed. Frohlich, INTERVENTION TRIALS - CONCERNS AND PUBLISHING PITFALLS, Hypertension, 28(1), 1996, pp. 1-2
SYMPOSIUM ON GENE-REGULATION IN HYPERTENSION AND CARDIOVASCULAR-DISEASES
Authors: FROHLICH ED GAVRAS H
Citation: Ed. Frohlich et H. Gavras, SYMPOSIUM ON GENE-REGULATION IN HYPERTENSION AND CARDIOVASCULAR-DISEASES, Hypertension, 27(4), 1996, pp. 979-979
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>